Proto Axiom invites you to the Challenger Summit
The Challenger Summit, facilitated by Corrs Chambers Westgarth, will feature a dynamic pitch competition showcasing ten of the country’s leading researchers, and a panel of experts from the Australian startup venture capital community, complemented by an international audience of asset managers.
Attendees will have the opportunity to gain in-depth knowledge about the latest trends and challenges in the sector by engaging with industry leaders such as Dr. Larry Marshall, former CEO of CSIRO; Dr. Peter Diamandis, Executive Chairman of the XPRIZE Foundation; Reed Jobs, Investor at Yosemite; Shivaune Field, Business Journalist at Forbes Australia; and Dr. Stephanie Allen, Partner at Kearney.
The Challenger Summit is a unique chance to immerse yourself in the forefront of innovation and be part of shaping its future.
Kind regards,
Anthony Liveris
CEO, Proto Axiom
CEO, Proto Axiom
Location
Corrs Chambers Westgarth
Level 37, Quay Quarter Tower,
50 Bridge Street, Sydney NSW 2000
Level 37, Quay Quarter Tower,
50 Bridge Street, Sydney NSW 2000
Date & Time
October 16, 2024
12:00 PM - 07:00PM
12:00PM - Welcome & Lunch
12:30PM - Pitch Sessions
01:50PM - Address by the Minister
02:00PM - Keynote Panel Session
02:45PM - Break
03:00PM - Pitch Sessions
04:20PM - Keynote Panel Session
05:00PM - Awards & Networking
12:00 PM - 07:00PM
12:00PM - Welcome & Lunch
12:30PM - Pitch Sessions
01:50PM - Address by the Minister
02:00PM - Keynote Panel Session
02:45PM - Break
03:00PM - Pitch Sessions
04:20PM - Keynote Panel Session
05:00PM - Awards & Networking
Keynote Panellists and Speakers
CEO, Corrs Chambers Westgarth
Gavin has over 20 years’ experience as a lawyer, including a decade based in Asia. He was named as an Innovative Leader in the 2020 Financial Times Innovative Lawyers Awards Asia Pacific.
FORMER CEO, CSIRO
Dr. Larry Marshall is a scientist, technology innovator, and business leader with more than 25 years' experience in creating new value and impact with science.
INVESTOR, YOSEMITE
Founder of venture capital firm Yosemite, which has raised more than $200 million to finance innovation in cancer care.
business journalist, forbes australia
Shivaune is a business journalist
reporting on tech and innovation. Field has reported extensively in the U.S. and Australia across print, digital, television, and podcast platforms.
reporting on tech and innovation. Field has reported extensively in the U.S. and Australia across print, digital, television, and podcast platforms.
partner, kearney
Stephanie is an eminent strategy partner with deep expertise in health care and in establishing partnerships to successfully tackle some of the world's most complex challenges.
founder & executive chairman, xprize foundation
Peter is the Founder and Executive Chairman of the XPRIZE Foundation, which leads the world in designing and operating large-scale incentive competitions.
senator, nsw
Andrew is a Liberal Senator for New South Wales. Prior to his election to Federal Parliament in 2019, Andrew was an author and accountant.
Judges
Senior partner, korn ferry
Kathy was the Senior Director of New Ventures, Australia and New Zealand (ANZ) for Johnson & Johnson Innovation. She also served as the Head of Innovation and Investment for Janssen Inc. ANZ.
Director, snow foundation
Derek has a commercial research background in biotechnology coupled with science and innovation policy experience in Government and university sectors.
Principal, main sequence ventures
Elaine has a rich background in science, entrepreneurship, and venture capital, and has invested in over 80 startups in Australia, the US, and SEA, and has founded several venture businesses.
Investment manager, tenmile
Michael Lamprecht is an Investment Manager at Tenmile, based in Sydney, specialising in biotechnology, startups, and early-stage investments.
science analyst, proto axiom
Laura has a strong background in academic research in chemistry. She is an experienced interdisciplinary researcher with a publication track record spanning medicinal chemistry, biochemistry and polymers.
Director external innovation, csl
Chris specialises in innovative biopharmaceutical solutions. With a strong background in research and development, Chris is committed to advancing healthcare through cutting-edge science and technology.
